학술논문

A0604 - Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer.
Document Type
Article
Source
European Urology. 2024 Supplement 1, Vol. 85, pS1517-S1518. 2p.
Subject
*RADICAL prostatectomy
*PROSTATE cancer
*QUALITY of life
Language
ISSN
0302-2838